学术探索
学术期刊
新闻热点
数据分析
智能评审

MARKED INVIVO ANTIRETROVIRUS ACTIVITY OF 9-(2-PHOSPHONYLMETHOXY-ETHYL)ADENINE, A SELECTIVE ANTI-HUMAN IMMUNODEFICIENCY VIRUS AGENT

被引：268
作者：
BALZARINI, J
NAESENS, L
HERDEWIJN, P
ROSENBERG, I
HOLY, A
PAUWELS, R
BABA, M
JOHNS, DG
DECLERCQ, E
机构：
[1] CZECHOSLOVAK ACAD SCI, INST ORGAN CHEM & BIOCHEM, CS-16610 PRAGUE 6, CZECHOSLOVAKIA
[2] NCI, DIV CANC TREATMENT, DEV THERAPEUT PROGRAM, BETHESDA, MD 20892 USA
来源：
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 1989年 / 86卷 / 01期
关键词：
D O I：
10.1073/pnas.86.1.332
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：332 / 336
页数：5
相关论文
共 28 条
  • [1] THE 2',3'-DIDEOXYRIBOSIDE OF 2,6-DIAMINOPURINE SELECTIVELY INHIBITS HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) REPLICATION INVITRO
    BALZARINI, J
    PAUWELS, R
    BABA, M
    ROBINS, MJ
    ZOU, R
    HERDEWIJN, P
    DECLERCQ, E
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 145 (01) : 269 - 276
  • [2] THE INVITRO AND INVIVO ANTI-RETROVIRUS ACTIVITY, AND INTRACELLULAR METABOLISM OF 3'-AZIDO-2',3'-DIDEOXYTHYMIDINE AND 2',3'-DIDEOXYCYTIDINE ARE HIGHLY DEPENDENT ON THE CELL SPECIES
    BALZARINI, J
    PAUWELS, R
    BABA, M
    HERDEWIJN, P
    DECLERCQ, E
    BRODER, S
    JOHNS, DG
    [J]. BIOCHEMICAL PHARMACOLOGY, 1988, 37 (05) : 897 - 903
  • [3] COMPARATIVE INHIBITORY EFFECTS OF SURAMIN AND OTHER SELECTED COMPOUNDS ON THE INFECTIVITY AND REPLICATION OF HUMAN T-CELL LYMPHOTROPIC VIRUS (HTLV-III) LYMPHADENOPATHY-ASSOCIATED VIRUS (LAV)
    BALZARINI, J
    MITSUYA, H
    DECLERCQ, E
    BRODER, S
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1986, 37 (03) : 451 - 457
  • [4] ON THE SHELF AIDS DRUG IN CLINICAL-TRIAL
    BARNES, DM
    [J]. SCIENCE, 1987, 238 (4825) : 276 - 276
  • [5] ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS)
    BARRESINOUSSI, F
    CHERMANN, JC
    REY, F
    NUGEYRE, MT
    CHAMARET, S
    GRUEST, J
    DAUGUET, C
    AXLERBLIN, C
    VEZINETBRUN, F
    ROUZIOUX, C
    ROZENBAUM, W
    MONTAGNIER, L
    [J]. SCIENCE, 1983, 220 (4599) : 868 - 871
  • [6] BRODER S, 1985, LANCET, V2, P627
  • [7] COLLINS JM, 1986, J CLIN PHARMACOL, V26, P22
  • [8] RIBAVIRIN TREATMENT OF THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS) AND THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME-RELATED COMPLEX (ARC) - A PHASE-1 STUDY SHOWS TRANSIENT CLINICAL IMPROVEMENT ASSOCIATED WITH SUPPRESSION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS AND ENHANCED LYMPHOCYTE-PROLIFERATION
    CRUMPACKER, C
    HEAGY, W
    BUBLEY, G
    MONROE, JE
    FINBERG, R
    HUSSEY, S
    SCHNIPPER, L
    LUCEY, D
    LEE, TH
    MCLANE, MF
    ESSEX, M
    MULDER, C
    [J]. ANNALS OF INTERNAL MEDICINE, 1987, 107 (05) : 664 - 674
  • [9] A NOVEL SELECTIVE BROAD-SPECTRUM ANTI-DNA VIRUS AGENT
    DECLERCQ, E
    HOLY, A
    ROSENBERG, I
    SAKUMA, T
    BALZARINI, J
    MAUDGAL, PC
    [J]. NATURE, 1986, 323 (6087) : 464 - 467
  • [10] DECLERCQ E, 1989, IN PRESS ANTIMICROB
123